Top Microbiome Sequencing Services Companies

Microbiome Sequencing Services Market size was valued at USD 1.54 Billion in 2023 and is poised to grow from USD 1.7 Billion in 2024 to USD 3.85 Billion by 2032, growing at a CAGR of 10.7% during the forecast period (2025-2032).

Several key players who provide robust sequencing technologies and services characterize the competitive environment of the global microbiome sequencing services market. Leading international companies like Illumina, Thermo Fisher Scientific, and BGI Genomics are at the forefront of high-throughput sequencing solutions. Other companies like Qiagen, Oxford Nanopore Technologies, and Zymo Research are also making their contribution towards the growth of the market with innovative products and increased service provision resulting in healthy competition and technological progression within the microbiome study sector.  'Charles River Laboratories ', 'Eurofins Scientific ', 'BGI ', 'Microbiome Insights Inc. ', 'MR DNA ', 'Baseclear BV ', 'Clinical Microbiomics AS ', 'Zymo Research ', 'Rancho Biosciences ', 'Metabiomics ', 'CosmosID ', 'ZIFO ', 'Shanghai Realbio Technology (RBT) Co., Ltd. ', 'Second Genome'

The global microbiome sequencing services market is being propelled by the progressive trend of personalized medicine. Since healthcare approaches are geared towards every individual, microbiome analysis is vital as it provides patient focused composition of microorganisms aiding in the diagnosis and management of the conditions. This leads to the increasing market for such solutions. 

Rising Integration of Artificial Intelligence in Microbiome Analysis: The global microbiome sequencing services market trends are seeing a drastic increase in the application of Artificial Intelligence and machine learning integrated technologies. Such tools assist with the enhanced analysis and understanding of more complex microbiome data towards better microbial functioning as well as health and disease preventive measures. 

North America dominates the global microbiome sequencing services market due to its strong research infrastructure, advanced technological capabilities, and substantial investments in biotechnology and healthcare sectors. The region consists of prominent colleges, research institutes, and biotechnology companies that advocate for, and carry out, microbiome research, respectively especially in the region of genomics and personalized medicine. Additionally, there is a sound regulatory framework already in place in North America enabling the operations of marketing advanced sequencing technologies. In addition, high levels of healthcare awareness, increase in the need for personalized medicine and growth in government funding for research regarding microbiome are also contributing to the dominance of North America in microbiome sequencing services market.